Philip Cohen

107.0k citations
489 papers · 89.2k indexed · 41 hit papers · h-index 143

Impact in

    • Protein Kinase Regulation and GTPase Signaling
    • PI3K/AKT/mTOR signaling in cancer
    • Melanoma and MAPK Pathways
    • Metabolism, Diabetes, and Cancer
    • Wnt/β-catenin signaling in development and cancer
    • Ubiquitin and proteasome pathways
    • Ion channel regulation and function
    • Mitochondrial Function and Pathology
  • Cell Biology top 0.01%

Papers in

    • Muscle metabolism and nutrition 45
    • Protein Kinase Regulation and GTPase Signaling 124
    • Melanoma and MAPK Pathways 53
    • Mitochondrial Function and Pathology 52
    • Metabolism, Diabetes, and Cancer 36
    • Ubiquitin and proteasome pathways 35

Philip Cohen

483 papers receiving 86.7k citations

Hit Papers

Kinase drug discovery 20 years after imatinib: progress and future directions 2021 · 670 citations
670197320261990200810002.0k3.0k

Peers

Philip Cohen
Comparison fields: 5 of 195
  • Molecular Biology 67.4k
  • Cell Biology 13.5k
  • Aging 1.3k
  • Cancer Research 6.6k
  • Cellular and Molecular Neuroscience 7.6k
Replace Roger J. Davis with:
Roger J. Davis United States
Paul Tempst United States
Dario R. Alessi United Kingdom
Nahum Sonenberg Canada
Tony Hunter United States
Hediye Erdjument‐Bromage United States
Kun‐Liang Guan United States
John Blenis United States
Pierre Chambon France
Steven P. Gygi United States
Philip Cohen relative to Roger J. Davis United States Roger J. Davis's profile →
Citations per field
00.5×1.5×
Roger J. Davis · 1×
Citations per year

Countries citing papers authored by Philip Cohen

Since Specialization
Citations

This map shows the geographic impact of Philip Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Cohen more than expected).

Fields of papers citing papers by Philip Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Cohen. The network helps show where Philip Cohen may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Cohen Line = papers co-authored together Philip Cohen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20246
2 20230
3 202116
4 201998
5 201913
6 201788
7 2013346
8
Synthesis, Pim kinase inhibitory potencies and in vitro antiproliferative activities of diversely substituted pyrrolo[2,3-a]carbazoles
20111
9 200749
10
The Electronic Discharge Summary - a Local Solution Succeeds
20032
11 2002368
12 200265
13 2000193
14 199648
15 1995139
16 199547
17
Activation of the MAP kinase pathway by the protein kinase raf
Hit paper breakdown →
1992727
18 199122
19 1988397
20 1979227

About Philip Cohen

Philip Cohen is a scholar working on Cell Biology, Molecular Biology, Rheumatology, Aging and Cancer Research, having authored 489 papers that have together received 89.2k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (124 papers), Glycogen Storage Diseases and Myoclonus (61 papers), Melanoma and MAPK Pathways (53 papers), Mitochondrial Function and Pathology (52 papers), NF-κB Signaling Pathways (47 papers), Muscle metabolism and nutrition (45 papers), Metabolism, Diabetes, and Cancer (36 papers) and Ubiquitin and proteasome pathways (35 papers). The work is most often cited by research in Molecular Biology (67.4k citations), Cell Biology (13.5k citations), Aging (1.3k citations), Cancer Research (6.6k citations) and Cellular and Molecular Neuroscience (7.6k citations). Philip Cohen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Dario R. Alessi, Sheelagh Frame, Matilde Caivano, Stephen Davies, Helen Reddy, Ana Cuenda, Brian A. Hemmings, Michel Goedert, Thomas S. Ingebritsen and James R. Woodgett. Their work appears in journals such as European Journal of Biochemistry, FEBS Letters, Biochemical Journal, Journal of Biological Chemistry and Biochemical Society Transactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026